NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study

NCT04306939

SuspendedN/A

Sponsor: University of Pittsburgh

Conditions: Chronic Pancreatitis, Inflammatory Bowel Diseases, Hepatitis, NASH - Nonalcoholic Steatohepatitis, Acute Pancreatitis

Interventions: venipuncture, Questionnaires, Additional Sample Collections

Countries: United States

This is a prospective, descriptive, observational research study designed to observe and document the clinical practice by domain experts, and how the knowledge of new findings that are published in the medical literature affect clinical decision making. The study will evaluate risk factors and co-variants, including genetic variants that are associated with disease progression such as pain, inflammation, organ dysfunction, disability and quality of life.

Eligibility overview

Sex: ALL

Age: 12 Years to

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

Case Subjects

* Clinical diagnosis of a chronic disease or disorder (ex. pancreatitis, hepatitis or fatty liver, inflammatory bowel disease, irritable bowel syndrome, diarrhea, constipation, chronic pain syndromes, diabetes, hypertension, cardiovascular disease, chronic kidney disease, chronic neurologic disorders, rheumatological disorders, endocrine disorders, chronic pulmonary diseases, sinorespiratory disorders, chronic skin diseases, cancers and related disorders)
* Ability to read and write in English;
* Ability to provide informed consent

Control Subjects

• UPMC patients age 12 years without a chronic disorder.

Exclusion Criteria:

* Chronic infectious disease as the primary medical problem
* Less than 12 years of age
* Inability of the subject to understand the protocol
* Inability to the subject provide informed consent
Locations (1)
  • Pittsburgh, Pennsylvania, United States